Compare Becton Dickinson and Co (BDX) vs State Street SPDR Bloomberg 1-3 Month T-Bill ETF (BIL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs State Street SPDR Bloomberg 1-3 Month T-Bill ETF — how do they compare? Becton Dickinson and Co trades at $154.29 (market cap $42.39B), while State Street SPDR Bloomberg 1-3 Month T-Bill ETF trades at $91.52. The key difference: Becton Dickinson and Co pays a 2.73% dividend while State Street SPDR Bloomberg 1-3 Month T-Bill ETF pays none, and State Street SPDR Bloomberg 1-3 Month T-Bill ETF is trading nearer its 52-week high, Becton Dickinson and Co nearer its low. Which is the better fit depends on your goals.
| BDX | BIL | |
|---|---|---|
Market Cap | $42.39B | — |
Sector | Health | Fixed Income |
52-Week High | $185.39 | $91.77 |
52-Week Low | $135.49 | $91.27 |
Enterprise Value | $58.85B | — |
Dividend Yield | 2.73% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL tracks the performance of short-term U.S. Treasury bills with maturities between 1 and 3 months. It is designed for investors seeking a highly liquid, low-risk vehicle for cash management and capital preservation.
Read more on BIL →
